19 research outputs found
Eligibility for palivizumab prophylaxis in a cohort of children with severe bronchiolitis
No full textPharmacist-driven respiratory syncytial virus prophylaxis stewardship service in a neonatal intensive care unit
No full text
Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value
No full textAn outbreak of respiratory tract infection due to Respiratory Syncytial Virus-B in a postpartum center
No full textSystematic Review of the Safety and Efficacy of Palivizumab among Infants and Young Children with Cystic Fibrosis
No full textRespiratory Distress in Human Metapneumovirus Infection with High-inflammatory Cytokinemia
No full textImpact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016–2017 epidemic season: a systematic review of seven Italian reports
No full text
